Actavis Group, the international generic pharmaceuticals company announced that Kéri Pharma Generics in Hungary will be rebranded as Actavis with immediate effect.This follows Actavis' acquisition of Kéri Pharma Generics in 2005 and the completed integration of the business.
Since its acquisition by Actavis, sales revenues of the company have grown dynamically, and in 2008 they are expected to exceed Ft 8 billion. The company has introduced a number of products successfully on the Hungarian market in recent years and plans to extend its portfolio with 16 additional products this year and a further 18 in 2009.
Kéri Pharma Generics will become formally known as Actavis Hungary and will continue to be led by Gábor Kéri, Country Manager.
Commenting, Robert Wessman, President and CEO of Actavis said “Our acquisition of Kéri Pharma Generics in 2005 marked Actavis' first steps into the Hungarian market with own-label products. The formal introduction of the Actavis name into the market is the final step in the integration process but just the beginning of the next stage in our development in this market. We have a solid platform from which to achieve further growth in Hungary.” (press release)